Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 82 Paclitaxel 78 Letrozole 76 pembrolizumab 71 Trastuzumab 63 Specimen Handling 63 Carboplatin 58 Magnetic Resonance Spectroscopy 50 ribociclib 49 Capecitabine 49 Anastrozole 47 pertuzumab 46 palbociclib 43 Cyclophosphamide 41 exemestane 40 abemaciclib 40 Tamoxifen 38 Biopsy 36 Docetaxel 30 trastuzumab deruxtecan 29 Taxes 28 Radiotherapy 27 130-nm albumin-bound paclitaxel 26 Gemcitabine 25 Blood Specimen Collection 25 Surveys and Questionnaires 23 olaparib 22 Standard of Care 22 sacituzumab govitecan 20 eribulin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Histocompatibility Testing × Breast × 90 days × Clear all

NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡